OBJECTIVE: To evaluate the effect of neonatal vaccination with bacille Calmette-Guérin (BCG) on tuberculin skin test (TST) reactivity over time and to define the optimal age-specific induration cut-offs to detect latent tuberculosis infection (LTBI). DESIGN: TSTs were performed on 783 children aged 3 months to 14 years who had received neonatal BCG. The estimated annual risk of LTBI was derived from TSTs administered to 2504 children aged 7 years who lacked BCG scars. Goodness-of-fit analysis was used to determine the optimal age-specific cut-off values. RESULTS: The effect of neonatal BCG on TST induration waned with age, reaching a nadir at age 6-7 years. This was followed by a rise in TST reactivity. The optimal age-specific TST cut-off values for the detection of LTBI was estimated to be respectively 21, 18, 13 and 10 mm at ages 0-1, 2-3, 4-5 and 6-7 years. There was a close correlation between these new cut-off values with the estimated risk of LTBI for the first 7 years of life (r = 0.93, P < 0.001). CONCLUSIONS: The effect of neonatal BCG on TST gradually declines over the first 7 years of life. Our proposed new age-specific TST induration cut-off values could help differentiate between response to BCG and LTBI in young children.
OBJECTIVE: To evaluate the effect of neonatal vaccination with bacille Calmette-Guérin (BCG) on tuberculin skin test (TST) reactivity over time and to define the optimal age-specific induration cut-offs to detect latent tuberculosis infection (LTBI). DESIGN: TSTs were performed on 783 children aged 3 months to 14 years who had received neonatal BCG. The estimated annual risk of LTBI was derived from TSTs administered to 2504 children aged 7 years who lacked BCG scars. Goodness-of-fit analysis was used to determine the optimal age-specific cut-off values. RESULTS: The effect of neonatal BCG on TST induration waned with age, reaching a nadir at age 6-7 years. This was followed by a rise in TST reactivity. The optimal age-specific TST cut-off values for the detection of LTBI was estimated to be respectively 21, 18, 13 and 10 mm at ages 0-1, 2-3, 4-5 and 6-7 years. There was a close correlation between these new cut-off values with the estimated risk of LTBI for the first 7 years of life (r = 0.93, P < 0.001). CONCLUSIONS: The effect of neonatal BCG on TST gradually declines over the first 7 years of life. Our proposed new age-specific TST induration cut-off values could help differentiate between response to BCG and LTBI in young children.
Authors: Saumil Doshi; Tina Fang Chen; Josue Zapata; Robert S Holzman; Luis C Zapata; Judith A Aberg; Sumathi Sivapalasingam Journal: Int J Infect Dis Date: 2012-04-26 Impact factor: 3.623
Authors: Roi Piñeiro; María José Mellado; María José Cilleruelo; Marta García-Ascaso; Antonio Medina-Claros; Milagros García-Hortelano Journal: Eur J Pediatr Date: 2012-07-01 Impact factor: 3.183
Authors: Sarah Burl; Uche J Adetifa; Momodou Cox; Ebrima Touray; Hilton Whittle; Helen McShane; Sarah L Rowland-Jones; Katie L Flanagan Journal: PLoS One Date: 2010-08-19 Impact factor: 3.240
Authors: Carina Marquez; Gabriel Chamie; Jane Achan; Anne F Luetkemeyer; Mary Kyohere; Jaffer Okiring; Grant Dorsey; Moses R Kamya; Edwin D Charlebois; Diane V Havlir Journal: Pediatr Infect Dis J Date: 2016-05 Impact factor: 2.129
Authors: Maitreyi Murthy; Sumithra Selvam; Nelson Jesuraj; Sean Bennett; Mark Doherty; Harleen M S Grewal; Mario Vaz Journal: PLoS One Date: 2013-09-06 Impact factor: 3.240